A Modular Method for Rapidly Prototyping Targeted Gas Vesicle Protein Nanoparticles

Gas vesicles (GVs) are air-filled protein nanoparticles that are proving to be useful in a number of biomedical applications. We hypothesized that it could be possible to develop a modular method for creating rapidly prototyped GVs by modifying their surface chemistry to include targeting peptides in an orientation-specific manner. Here, we describe a modular method to create targeted GVs using His-tagged antibody fragments, ensuring that the antibody fragments are connected to the GV in an orientation-specific manner. This is achieved via the functionalization of the GVs with the nickel-nitrilotriacetic acid (Ni-NTA) group. First, we validated that these functionalized GVs can bind His-tagged green fluorescent protein and characterized the particle size and surface charge of functionalized GVs. Then, GVs targeted to prostate-specific membrane antigen (PSMA) using a minibody were validated using a knockout validation <i>in vitro</i>.

Authors

Institutions

Publication Details

Journal
Bioconjugate Chemistry
Published
2026-01-19
DOI
https://doi.org/10.1021/acs.bioconjchem.5c00387
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Modular Method for Rapidly Prototyping Targeted Gas Vesicle Protein Nanoparticles

Hongyi Li, Ann Liu, Septimiu E. Salcudean, Nicole Robinson et al.
Bioconjugate Chemistry
Nanoparticle-Based Drug Delivery
article

A Modular Method for Rapidly Prototyping Targeted Gas Vesicle Protein Nanoparticles

Hongyi Li, Ann Liu, Septimiu E. Salcudean, Nicole Robinson, Mikhail G. Shapiro, Reid Vassallo, Bill Ling, Ernesto Criado-Hidalgo, George Daghlian, Dina Malounda, Erik Schrunk, Peter Black, S. Larry Goldenberg, Michael E. Cox, Margaret B. Swift
article en

Abstract

Gas vesicles (GVs) are air-filled protein nanoparticles that are proving to be useful in a number of biomedical applications. We hypothesized that it could be possible to develop a modular method for creating rapidly prototyped GVs by modifying their surface chemistry to include targeting peptides in an orientation-specific manner. Here, we describe a modular method to create targeted GVs using His-tagged antibody fragments, ensuring that the antibody fragments are connected to the GV in an orientation-specific manner. This is achieved via the functionalization of the GVs with the nickel-nitrilotriacetic acid (Ni-NTA) group. First, we validated that these functionalized GVs can bind His-tagged green fluorescent protein and characterized the particle size and surface charge of functionalized GVs. Then, GVs targeted to prostate-specific membrane antigen (PSMA) using a minibody were validated using a knockout validation <i>in vitro</i>.

Bioconjugate ChemistryVol. 37(2)
California Institute of Technology (US), Howard Hughes Medical Institute (US), University of British Columbia (CA), Division of Chemistry (US)
Openalex Percentile: Top 85%
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.